Home

CVS Health Corp (CVS)

79.34
+1.53 (1.96%)
NYSE · Last Trade: Nov 17th, 1:28 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close77.81
Open77.91
Bid79.32
Ask79.35
Day's Range77.74 - 79.87
52 Week Range43.56 - 85.15
Volume2,127,560
Market Cap104.69B
PE Ratio (TTM)203.42
EPS (TTM)0.4
Dividend & Yield2.660 (3.35%)
1 Month Average Volume7,505,566

Chart

About CVS Health Corp (CVS)

CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More

News & Press Releases

Health Insurance Providers Stocks Q3 Highlights: Cigna (NYSE:CI)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Cigna (NYSE:CI) and its peers.
Via StockStory · November 16, 2025
Trump's Bond Buying Spree Surges Past $82 Million Since Augustbenzinga.com
Trump bought over $82 million in bonds, intersecting with sectors boosted by his policies. Disclosures show 175+ transactions.
Via Benzinga · November 15, 2025
Hedge Fund Sells $25.6 Million in Paramount Group Stock as Rithm's $1.6 Billion Deal Loomsfool.com
A surprising office-sector exit by a steady fund may reveal more about opportunity cost than pessimism.
Via The Motley Fool · November 15, 2025
What One Hedge Fund's $29.6 Million Bet on First American Signals About the U.S. Housing Marketfool.com
One quiet hedge fund is making a contrarian move on a real-estate-linked stock just as the housing market starts to turn.
Via The Motley Fool · November 15, 2025
Why One Fund Just Invested $21 Million in This Once High-Flying Software Stockfool.com
This hedge fund just made a bold move into a once-hyped software name that’s now trading at a steep discount.
Via The Motley Fool · November 15, 2025
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm
LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna Medicare Advantage plans through CVS Health Corporation (“CVS”) for breach of contract and related violations of state laws.
By Schall Law · Via GlobeNewswire · November 14, 2025
David Tepper's Contrarian Bet on UnitedHealth Group (UNH) Pays Off Amidst Market Volatility
In a move that has captured the attention of the financial world, legendary investor David Tepper, through his firm Appaloosa Management, made a significant contrarian bet on healthcare giant UnitedHealth Group Inc. (NYSE: UNH) during the second quarter of 2025. Far from indicating a negative portfolio impact, Tepper's aggressive increase
Via MarketMinute · November 13, 2025
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.fool.com
These companies are demonstrating their ability to deal with significant business risks.
Via The Motley Fool · November 12, 2025
3 Stocks That Have Made Epic Comebacks in 2025fool.com
Last year was a bad one for these stocks, but buying them on weakness would have proven to be a great move for investors.
Via The Motley Fool · November 12, 2025
A Look Into CVS Health Inc's Price Over Earningsbenzinga.com
Via Benzinga · November 12, 2025
Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switchbenzinga.com
Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India to defend market share.
Via Benzinga · November 12, 2025
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'benzinga.com
Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."
Via Benzinga · November 12, 2025
CVS Health Is Soaring 75% This Year. And the Stock Still Looks Cheap.fool.com
The company replaced its CEO last year, and the turnaround has been going well.
Via The Motley Fool · November 11, 2025
Pete Buttigieg Slams Trump's 'Bad Deal' On Health Insurance, Cites CBO Estimate Of 10% Premium Hikes: 'Losing On The Economy'benzinga.com
Pete Buttigieg says Trump's ATC attack is a distraction from his "bad deal" on health insurance and failure on "everyday life" costs.
Via Benzinga · November 11, 2025
Market Breathes Sigh of Relief: A Comprehensive Outlook Post-Government Shutdown Resolution
The financial markets are experiencing a significant resurgence of optimism as the United States government concludes its prolonged shutdown, which, at 40 days, marked the longest in the nation's history. This anticipated resolution, reached on November 10, 2025, through a Senate deal, has injected a palpable sense of relief across
Via MarketMinute · November 10, 2025
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To Decemberbenzinga.com
Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to December and raising premium concerns.
Via Benzinga · November 10, 2025
UnitedHealth Group Stumbles Amidst Renewed Antitrust Scrutiny, Defying Bullish Market Trend
In a surprising turn of events on November 10, 2025, UnitedHealth Group (NYSE: UNH), a titan in the healthcare industry, saw its stock tumble significantly, shedding several percentage points of its market capitalization. This downturn sharply contrasted with a generally buoyant market, where major indices like the S&P 500
Via MarketMinute · November 10, 2025
Unpacking Q3 Earnings: Centene (NYSE:CNC) In The Context Of Other Health Insurance Providers Stocks
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Centene (NYSE:CNC) and its peers.
Via StockStory · November 9, 2025
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.fool.com
Healthcare stocks in the S&P 500 offer an average dividend yield of 1.8%.
Via The Motley Fool · November 9, 2025
Can CVS Health Maintain Its Growth Through the End of 2025?fool.com
The company's prospects are looking up.
Via The Motley Fool · November 8, 2025
U.S. Labor Market Flashes Warning Signs: A November 2025 Economic Crossroads
The U.S. labor market is signaling a significant shift as November 2025 draws to a close, presenting a complex picture of decelerating job growth, a concerning surge in layoffs, and weakening consumer confidence. This mixed economic data is amplifying expectations for further interest rate cuts by the Federal Reserve,
Via MarketMinute · November 7, 2025
Humana Faces Steep Decline Amidst Broad Market Downturn: A Look at Potential Triggers and Industry Repercussions
November 6, 2025 – Humana Inc. (NYSE: HUM) shares experienced a significant downturn today, mirroring a broader negative trend across the market. While specific real-time triggers for this hypothetical date are beyond current predictive capabilities, the scenario points to a confluence of factors that could typically impact a major health insurer,
Via MarketMinute · November 6, 2025
5 Revealing Analyst Questions From CVS Health’s Q3 Earnings Call
CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health insurance, with management attributing results to improved execution in retail pharmacy, market share gains, and early progress on Aetna’s operational turnaround. CEO David Joyner emphasized that CVS’s “diversified business and progress on becoming the most trusted health care company” helped offset reimbursement pressures and challenges in Health Care Delivery. The company’s decision to slow Oak Street Health clinic expansion and focus on closing underperforming clinics also featured prominently, as did continued investment in technology and customer service.
Via StockStory · November 5, 2025
What the Options Market Tells Us About CVS Healthbenzinga.com
Via Benzinga · October 31, 2025
Why CVS Health (CVS) Stock Is Falling Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health Care Delivery business, which overshadowed otherwise strong third-quarter results. 
Via StockStory · October 30, 2025